Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.
SZSE:300357.SZ
26.98 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||||||||
Current Assets: | |||||||||||||||
Cash & Cash Equivalents
| 1,171.377 | 840.688 | 649.994 | 583.68 | 750.771 | 460.043 | 185.814 | 235.474 | 271.807 | 275.475 | 103.336 | 64.055 | 42 | 27.427 | 43.487 |
Short Term Investments
| 117.387 | 295.054 | 370.934 | 307.034 | 41.371 | 13 | 300 | 171 | 100 | 60 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 1,288.764 | 1,135.742 | 1,020.929 | 890.714 | 792.142 | 460.043 | 185.814 | 235.474 | 271.807 | 275.475 | 103.336 | 64.055 | 42 | 27.427 | 43.487 |
Net Receivables
| 214.937 | 284.913 | 256.17 | 220.533 | 211.021 | 179.181 | 149.45 | 117.885 | 103.317 | 99.531 | 85.292 | 66.62 | 49.338 | 27.566 | 19.212 |
Inventory
| 59.038 | 48.411 | 53.751 | 48.331 | 36.819 | 23.473 | 19.827 | 14.041 | 9.155 | 11.913 | 7.967 | 5.036 | 4.619 | 3.604 | 3.766 |
Other Current Assets
| 7.155 | 8.067 | 10.661 | 11.36 | 10.022 | 118.961 | 301.405 | 171.815 | 100 | 60 | -1.512 | -0.863 | -0.97 | -0.649 | 9 |
Total Current Assets
| 1,569.894 | 1,477.133 | 1,341.511 | 1,170.938 | 1,050.003 | 781.658 | 656.497 | 539.215 | 484.279 | 446.919 | 195.084 | 134.848 | 94.987 | 57.949 | 75.465 |
Non-Current Assets: | |||||||||||||||
Property, Plant & Equipment, Net
| 704.841 | 444.605 | 301.618 | 240.162 | 197.633 | 137.681 | 123.564 | 118.53 | 96.971 | 60.282 | 48.431 | 38.731 | 36.609 | 38.618 | 32.307 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 188.42 | 189.497 | 176.35 | 170.422 | 160.939 | 123.351 | 53.141 | 36.76 | 27.784 | 21.786 | 19.404 | 16.197 | 14.582 | 13.174 | 12.507 |
Goodwill and Intangible Assets
| 188.42 | 189.497 | 176.35 | 170.422 | 160.939 | 123.351 | 53.141 | 36.76 | 27.784 | 21.786 | 19.404 | 16.197 | 14.582 | 13.174 | 12.507 |
Long Term Investments
| -43.174 | -216.653 | -287.584 | -293.174 | -28.241 | 0 | 13 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 |
Tax Assets
| 5.035 | 4.872 | 5.809 | 4.896 | 3.669 | 1.882 | 1.72 | 1.681 | 1.277 | 1.305 | 1.036 | 0.689 | 0.708 | 0.737 | 0.708 |
Other Non-Current Assets
| 137.151 | 298.422 | 394.258 | 311.511 | 44.207 | 13.32 | 0.389 | 0.708 | 1.176 | 1.015 | 0 | 0.649 | 0.302 | 0.046 | 0.397 |
Total Non-Current Assets
| 992.273 | 720.743 | 590.45 | 433.817 | 378.207 | 276.234 | 191.814 | 157.68 | 127.208 | 84.388 | 68.871 | 56.265 | 52.2 | 52.575 | 45.919 |
Total Assets
| 2,562.167 | 2,197.875 | 1,931.961 | 1,604.756 | 1,428.211 | 1,057.893 | 848.311 | 696.895 | 611.488 | 531.307 | 263.955 | 191.113 | 147.188 | 110.524 | 121.384 |
Liabilities & Equity: | |||||||||||||||
Current Liabilities: | |||||||||||||||
Account Payables
| 7.992 | 7.683 | 5.085 | 5.663 | 8.684 | 3.447 | 1.38 | 1.027 | 0.598 | 0.999 | 0.597 | 0.63 | 0.625 | 0.737 | 4.596 |
Short Term Debt
| 41.187 | 3.98 | 5.859 | 5.092 | -0.16 | -0.28 | -0.097 | -2.065 | 0 | 0 | 0 | 0 | 10 | 10 | 0 |
Tax Payables
| 14.502 | 30.315 | 62.931 | 13.035 | 13.218 | 25.065 | 16.703 | 3.921 | 4.821 | 7.901 | 4.66 | 4.795 | 4.042 | 2.505 | 0.253 |
Deferred Revenue
| 0.384 | -0 | 0.417 | 0.441 | 0.16 | 0.28 | 0.097 | 2.065 | 0 | 0 | 0 | 0 | 6.278 | 5.779 | 0 |
Other Current Liabilities
| 127.477 | 91.089 | 96.635 | 44.223 | 51.345 | 54.171 | 40.82 | 35.438 | 24.03 | 15.204 | 11.438 | 7.333 | 0.021 | 0.023 | 0.472 |
Total Current Liabilities
| 177.04 | 102.751 | 107.997 | 55.42 | 60.03 | 57.619 | 42.2 | 36.465 | 24.629 | 16.203 | 12.035 | 7.963 | 16.924 | 16.539 | 5.068 |
Non-Current Liabilities: | |||||||||||||||
Long Term Debt
| 21.256 | 12.283 | 1.947 | 4.717 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 30.932 | 27.428 | 24.914 | 20.631 | 16.131 | 4.853 | 4.853 | 4.853 | 3.945 | 1.55 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0.203 | 0.079 | 0.499 | 0.557 | 0.093 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 29.029 | 28.219 | 0 | -4.717 | 0 | 0 | 0 | 0 | 0 | 0 | 0.885 | 1.77 | 2.656 | 3.541 | 4.426 |
Total Non-Current Liabilities
| 81.42 | 68.009 | 27.36 | 21.188 | 16.223 | 4.853 | 4.853 | 4.853 | 3.945 | 1.55 | 0.885 | 1.77 | 2.656 | 3.541 | 4.426 |
Total Liabilities
| 258.46 | 170.76 | 135.356 | 76.608 | 76.253 | 62.472 | 47.053 | 41.318 | 28.574 | 17.753 | 12.035 | 9.733 | 19.58 | 20.08 | 9.494 |
Equity: | |||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.017 | 0.019 | 0 | 0 | 0 | 0 |
Common Stock
| 523.584 | 523.584 | 523.584 | 523.584 | 523.584 | 290.88 | 161.6 | 161.6 | 161.6 | 161.6 | 90 | 90 | 90 | 86.954 | 126.809 |
Retained Earnings
| 1,262.575 | 1,092.707 | 889.636 | 647.499 | 494.301 | 532.563 | 388.303 | 261.356 | 201.691 | 144.134 | 145.436 | 81.931 | 33.538 | 3.084 | -14.979 |
Accumulated Other Comprehensive Income/Loss
| 270.746 | 235.142 | 194.653 | 156.631 | 124.916 | 93.645 | 251.355 | 50.911 | 37.912 | -0.017 | -0.019 | 0 | 0 | 0 | 0 |
Other Total Stockholders Equity
| 128.194 | 128.194 | 128.194 | 128.194 | 128.194 | 52.43 | 0 | 181.71 | 181.71 | 207.816 | 16.473 | 9.426 | 4.042 | 0.379 | 0.033 |
Total Shareholders Equity
| 2,185.099 | 1,979.627 | 1,736.068 | 1,455.909 | 1,270.996 | 969.517 | 801.258 | 655.577 | 582.913 | 513.55 | 251.91 | 181.357 | 127.58 | 90.417 | 111.863 |
Total Equity
| 2,303.706 | 2,027.115 | 1,796.605 | 1,528.148 | 1,351.958 | 995.421 | 801.258 | 655.577 | 582.913 | 513.554 | 251.919 | 181.38 | 127.608 | 90.444 | 111.89 |
Total Liabilities & Shareholders Equity
| 2,562.167 | 2,197.875 | 1,931.961 | 1,604.756 | 1,428.211 | 1,057.893 | 848.311 | 696.895 | 611.488 | 531.307 | 263.955 | 191.113 | 147.188 | 110.524 | 121.384 |